Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, BridgeBio Pharma Inc’s stock clocked out at $27.71, up 0.80% from its previous closing price of $27.49. In other words, the price has increased by $0.80 from its previous closing price. On the day, 1.87 million shares were traded. BBIO stock price reached its highest trading level at $28.18 during the session, while it also had its lowest trading level at $27.45.
Ratios:
To gain a deeper understanding of BBIO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.19 and its Current Ratio is at 3.19.
On September 04, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $46.Piper Sandler initiated its Overweight rating on September 04, 2024, with a $46 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 19 ’24 when Kumar Neil sold 27,389 shares for $22.41 per share. The transaction valued at 613,826 led to the insider holds 4,897,443 shares of the business.
STEPHENSON BRIAN C sold 4,156 shares of BBIO for $93,137 on Nov 19 ’24. The Secretary, Treasurer & CFO now owns 93,758 shares after completing the transaction at $22.41 per share. On Nov 19 ’24, another insider, BRIAN STEPHENSON, who serves as the Officer of the company, bought 4,156 shares for $22.35 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBIO now has a Market Capitalization of 5236912640 and an Enterprise Value of 6711862272. For the stock, the TTM Price-to-Sale (P/S) ratio is 23.89. Its current Enterprise Value per Revenue stands at 30.822 whereas that against EBITDA is -13.163.
Stock Price History:
Over the past 52 weeks, BBIO has reached a high of $44.32, while it has fallen to a 52-week low of $21.62. The 50-Day Moving Average of the stock is 8.30%, while the 200-Day Moving Average is calculated to be 3.82%.
Shares Statistics:
It appears that BBIO traded 2.05M shares on average per day over the past three months and 1659850 shares per day over the past ten days. A total of 188.99M shares are outstanding, with a floating share count of 147.70M. Insiders hold about 21.82% of the company’s shares, while institutions hold 75.80% stake in the company. Shares short for BBIO as of 1732838400 were 16998642 with a Short Ratio of 8.29, compared to 1730332800 on 17199451. Therefore, it implies a Short% of Shares Outstanding of 16998642 and a Short% of Float of 13.81.
